Negative Symptoms in Schizophrenia: Where We have been and Where We are Heading

被引:23
|
作者
Azorin, Jean-Michel [1 ]
Belzeaux, Raoul [1 ]
Adida, Marc [1 ]
机构
[1] St Marguerite Hosp, Dept Psychiat, F-13274 Marseille 9, France
关键词
History; Negative symptoms; Pathophysiology; Psychopathology; Schizophrenia; Treatment; DOUBLE-BLIND; RANDOMIZED-TRIAL; FEARFUL FACES; THERAPY; ANHEDONIA; AUGMENTATION; METAANALYSIS; ACTIVATION; CLOZAPINE; RESPONSES;
D O I
10.1111/cns.12292
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This review traces the history of negative symptom profiles in neuropsychiatry from their earliest emergence in the 19th century to the current psychiatric concepts and therapeutic approaches. Recent investigations performing exploratory and confirmatory factor analysis have suggested that negative symptoms are multidimensional, including evidence for at least two distinct negative symptom subdomains: diminished expression and amotivation. Preliminary studies have demonstrated the clinical validity of this distinction. Several potential pathophysiological validating factors based on brain imaging analysis of emotional experiences and expressions in individuals with schizophrenia are examined. Finally, the potential of different treatment strategies, including medications and various psychotherapeutic techniques, to most favorably treat each of these subdomains is discussed.
引用
收藏
页码:801 / 808
页数:8
相关论文
共 50 条
  • [1] Revisiting the Diagnosis of Schizophrenia: Where have we been and Where are We Going?
    Keller, William R.
    Fischer, Bernard A.
    Carpenter, William T., Jr.
    CNS NEUROSCIENCE & THERAPEUTICS, 2011, 17 (02) : 83 - 88
  • [2] Treatment of negative symptoms: Where do we stand, and where do we go?
    Aleman, Andre
    Lincoln, Tania M.
    Bruggeman, Richard
    Melle, Ingrid
    Arends, Johan
    Arango, Celso
    Knegtering, Henderikus
    SCHIZOPHRENIA RESEARCH, 2017, 186 : 55 - 62
  • [3] Where have we been? Where are we going?
    Gildenberg, PL
    STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 1997, 68 (1-4) : 1 - 9
  • [4] Tocolysis for Acute Preterm Labor: Where Have We Been, Where Are We Now, and Where are We Going?
    Navathe, Reshama
    Berghella, Vincenzo
    AMERICAN JOURNAL OF PERINATOLOGY, 2016, 33 (03) : 229 - 235
  • [5] Where Have We Been and Where Are We Going with Mindfulness in Schools?
    Weare, Katherine
    MINDFULNESS, 2023, 14 (02) : 293 - 299
  • [6] Critical care - where have we been and where are we going?
    Vincent, Jean-Louis
    CRITICAL CARE, 2013, 17
  • [7] THE NEUROBIOLOGY OF ADDICTION: WHERE WE HAVE BEEN AND WHERE WE ARE GOING
    Koob, George F.
    Simon, Eric J.
    JOURNAL OF DRUG ISSUES, 2009, 39 (03) : 759 - 776
  • [8] THE NEUROBIOLOGY OF ADDICTION: WHERE WE HAVE BEEN AND WHERE WE ARE GOING
    Koob, George F.
    Simon, Eric J.
    JOURNAL OF DRUG ISSUES, 2009, 39 (01) : 115 - 132
  • [9] Cognitive Behavior Therapy for Psychosis: Where Have We Been and Where Are We Going?
    Velligan, Dawn I.
    SCHIZOPHRENIA BULLETIN, 2009, 35 (05) : 857 - 858
  • [10] The Surviving Sepsis Campaign: Where have we been and where are we going?
    Dellinger, R. Phillip
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2014, 82 (04) : 237 - 244